Publikationen, an denen er mitarbeitet JOSE MANUEL CAMESELLE TEIJEIRO (29)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2021

  1. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

    Scientific Reports, Vol. 11, Núm. 1

  2. The Authors Reply PMC and PMT: Real Medicine and Not Just Biology

    American Journal of Surgical Pathology

2020

  1. GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

    Frontiers in Endocrinology, Vol. 11

  2. Sequential colocalization of ERa, PR, and AR hormone receptors using confocal microscopy enables new insights into normal breast and prostate tissue and cancers

    Cancers, Vol. 12, Núm. 12, pp. 1-22

  3. Thyroid papillary microtumor: Validation of the (updated) porto proposal assessing sex hormone receptor expression and mutational BRAF gene status

    American Journal of Surgical Pathology, Vol. 44, Núm. 9, pp. 1161-1172

2019

  1. Early colorectal cancers provide new evidence for a lynch syndrome-to-CMMRD phenotypic continuum

    Cancers, Vol. 11, Núm. 8

  2. Early evolutionary divergence between papillary and anaplastic thyroid cancers

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, Núm. 11, pp. 1843

  3. Novel TMEM127 Variant Associated to Bilateral Phaeochromocytoma with an Uncommon Clinical Presentation

    Case Reports in Endocrinology, Vol. 2019

2018

  1. Early evolutionary divergence between papillary and anaplastic thyroid cancers

    Annals of Oncology, Vol. 29, Núm. 6, pp. 1454-1460

2017

  1. Corrigendum: Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells (Oncogene (2010) 30 (1302-1317) DOI: 10.1038/onc.2010.512)

    Oncogene

  2. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

    Oncogene, Vol. 36, Núm. 5, pp. 652-666

  3. The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways

    Scientific Reports, Vol. 7

2015

  1. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

    International Journal of Cancer, Vol. 137, Núm. 8, pp. 1870-1878

2014

  1. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families

    Clinical Genetics, Vol. 85, Núm. 6, pp. 583-588

2013

  1. Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 6, pp. 2431-2441

2012

  1. Aplicación de proteómica a la búsqueda de nuevos mecanismos tumorales en cáncer de tiroides

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 114-114

2011

  1. Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells

    Oncogene, Vol. 30, Núm. 11, pp. 1302-1317